查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1459787

多重检测市场（产品：仪器、耗材和软体；技术：多重 RT-PCR、流式细胞仪、萤光和发光）- 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Multiplex Assays Market (Product: Instruments, Consumables, and Software; and Technology: Multiplex RT-PCR, Flow Cytometry, Fluorescence, and Luminescence) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 333 Pages | 商品交期: 2-10个工作天内

价格

多重分析市场 - 报告范围

TMR 关于全球多重分析市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球多重分析市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。该报告也提供了2023年至2031年全球多重检测市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解多重分析市场。

市场概况
2022年市场价​​值 32亿美元
2031 年市场价值 59 亿美元
CAGR 6.9%

该报告深入探讨了全球多重分析市场的竞争格局。全球多重分析市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球多重分析市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依产品分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按产品，2017-2031
    • 仪器
    • 耗材
      • 试剂和试剂盒
      • 微量移液管和微孔板
      • 其他的
    • 软体
  • 市场吸引力：依产品分类

第 7 章：全球市场分析与预测：依技术分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依技术分类，2017-2031
    • 多重RT-PCR
    • 流式细胞仪
    • 发光
    • 萤光
    • 其他的
    • 市场吸引力：依技术分类

第 8 章：全球市场分析与预测：按类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按类型，2017-2031
    • 蛋白质
      • 平面
      • 基于珠子
    • 核酸
      • 平面
      • 基于珠子
    • 细胞
  • 市场吸引力：按类型

第 9 章：全球市场分析与预测：按应用分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依应用分类，2017-2031
    • 研究和发展
      • 药物发现与研究
      • 生物标记研究与应用
    • 诊断
      • 传染性疾病
      • 自体免疫疾病
      • 癌症
      • 心血管疾病
      • 神经内分泌疾病
      • 其他的
    • 其他的
  • 市场吸引力：按应用分类

第 10 章：全球市场分析与预测：按最终用户

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 生物技术和生物製药公司
    • 学术与研究中心
    • 诊断中心
    • 医院
    • 其他的
  • 市场吸引力：按最终用户划分

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • DiaSorin SpA
    • Thermo Fisher Scientific, Inc.
    • Seegene, Inc.
    • Meso Scale Diagnostics, LLC
    • Abcam Limited
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Quansys Biosciences
    • Illumina, Inc.
Product Code: TMRGL49884

Multiplex Assays Market - Scope of Report

TMR's report on the global multiplex assayss market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global multiplex assayss market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global multiplex assayss market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the multiplex assayss market.

Market Snapshot
Market Value in 2022US$ 3.2 Bn
Market Value in 2031US$ 5.9 Bn
CAGR6.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global multiplex assayss market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global multiplex assayss market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global multiplex assayss market.

The report delves into the competitive landscape of the global multiplex assayss market. Key players operating in the global multiplex assayss market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global multiplex assayss market profiled in this report.

Key Questions Answered in Global multiplex assayss Market Report:

  • What is the sales/revenue generated by multiplex assayss across all regions during the forecast period?
  • What are the opportunities in the global multiplex assayss market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Multiplex Assays Market - Research Objectives and Research Approach

The comprehensive report on the global multiplex assayss market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global multiplex assayss market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global multiplex assayss market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Multiplex Assays Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Multiplex Assays Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Multiplex Assays Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Instruments
    • 6.3.2. Consumables
      • 6.3.2.1. Reagents & Kits
      • 6.3.2.2. Micropipettes & Microplates
      • 6.3.2.3. Others
    • 6.3.3. Software
  • 6.4. Market Attractiveness, by Product

7. Global Multiplex Assays Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Multiplex RT-PCR
    • 7.3.2. Flow Cytometry
    • 7.3.3. Luminescence
    • 7.3.4. Fluorescence
    • 7.3.5. Others
    • 7.3.6. Market Attractiveness, by Technology

8. Global Multiplex Assays Market Analysis and Forecast, By Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Type, 2017-2031
    • 8.3.1. Protein
      • 8.3.1.1. Planar
      • 8.3.1.2. Bead-based
    • 8.3.2. Nucleic Acid
      • 8.3.2.1. Planar
      • 8.3.2.2. Bead-based
    • 8.3.3. Cell
  • 8.4. Market Attractiveness, By Type

9. Global Multiplex Assays Market Analysis and Forecast, by Application

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Application, 2017-2031
    • 9.3.1. Research & Development
      • 9.3.1.1. Drug Discovery & Research
      • 9.3.1.2. Biomarker Research & Application
    • 9.3.2. Diagnosis
      • 9.3.2.1. Infectious Diseases
      • 9.3.2.2. Autoimmune Diseases
      • 9.3.2.3. Cancer
      • 9.3.2.4. Cardiovascular Diseases
      • 9.3.2.5. Neuroendocrine Diseases
      • 9.3.2.6. Others
    • 9.3.3. Others
  • 9.4. Market Attractiveness, by Application

10. Global Multiplex Assays Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Biotechnology & Biopharmaceutical Companies
    • 10.3.2. Academic & Research Centers
    • 10.3.3. Diagnostic Centers
    • 10.3.4. Hospitals
    • 10.3.5. Others
  • 10.4. Market Attractiveness, by End-user

11. Global Multiplex Assays Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Multiplex Assays Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Instruments & Software
    • 12.2.2. Kits & Reagents
    • 12.2.3. Services
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Conventional PCR
    • 12.4.2. Singleplex PCR
    • 12.4.3. Multiplex PCR
    • 12.4.4. Real-time PCR
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, By Type, 2017-2031
    • 12.6.1. Protein
      • 12.6.1.1. Planar
      • 12.6.1.2. Bead-based
    • 12.6.2. Nucleic Acid
      • 12.6.2.1. Planar
      • 12.6.2.2. Bead-based
    • 12.6.3. Cell
  • 12.7. Market Attractiveness, By Type
  • 12.8. Market Value Forecast, by Application, 2017-2031
    • 12.8.1. Companion Animal
    • 12.8.2. Livestock Animal
  • 12.9. Market Attractiveness, by Application
  • 12.10. Market Value Forecast, by End-user, 2017-2031
    • 12.10.1. Biotechnology & Biopharmaceutical Companies
    • 12.10.2. Academic & Research Centers
    • 12.10.3. Diagnostic Centers
    • 12.10.4. Hospitals
    • 12.10.5. Others
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Product
    • 12.13.2. By Technology
    • 12.13.3. By Type
    • 12.13.4. By Application
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Multiplex Assays Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Instruments
    • 13.2.2. Consumables
      • 13.2.2.1. Reagents & Kits
      • 13.2.2.2. Micropipettes & Microplates
      • 13.2.2.3. Others
    • 13.2.3. Software
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Multiplex RT-PCR
    • 13.4.2. Flow Cytometry
    • 13.4.3. Luminescence
    • 13.4.4. Fluorescence
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, By Type, 2017-2031
    • 13.6.1. Protein
      • 13.6.1.1. Planar
      • 13.6.1.2. Bead-based
    • 13.6.2. Nucleic Acid
      • 13.6.2.1. Planar
      • 13.6.2.2. Bead-based
    • 13.6.3. Cell
  • 13.7. Market Attractiveness, By Type
  • 13.8. Market Value Forecast, by Application, 2017-2031
    • 13.8.1. Research & Development
      • 13.8.1.1. Drug Discovery & Research
      • 13.8.1.2. Biomarker Research & Application
    • 13.8.2. Diagnosis
      • 13.8.2.1. Infectious Diseases
      • 13.8.2.2. Autoimmune Diseases
      • 13.8.2.3. Cancer
      • 13.8.2.4. Cardiovascular Diseases
      • 13.8.2.5. Neuroendocrine Diseases
      • 13.8.2.6. Others
    • 13.8.3. Others
  • 13.9. Market Attractiveness, by Application
  • 13.10. Market Value Forecast, by End-user, 2017-2031
    • 13.10.1. Biotechnology & Biopharmaceutical Companies
    • 13.10.2. Academic & Research Centers
    • 13.10.3. Diagnostic Centers
    • 13.10.4. Hospitals
    • 13.10.5. Others
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Product
    • 13.13.2. By Technology
    • 13.13.3. By Type
    • 13.13.4. By Application
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Multiplex Assays Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Instruments
    • 14.2.2. Consumables
      • 14.2.2.1. Reagents & Kits
      • 14.2.2.2. Micropipettes & Microplates
      • 14.2.2.3. Others
    • 14.2.3. Software
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Multiplex RT-PCR
    • 14.4.2. Flow Cytometry
    • 14.4.3. Luminescence
    • 14.4.4. Fluorescence
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, By Type, 2017-2031
    • 14.6.1. Protein
      • 14.6.1.1. Planar
      • 14.6.1.2. Bead-based
    • 14.6.2. Nucleic Acid
      • 14.6.2.1. Planar
      • 14.6.2.2. Bead-based
    • 14.6.3. Cell
  • 14.7. Market Attractiveness, By Type
  • 14.8. Market Value Forecast, by Application, 2017-2031
    • 14.8.1. Research & Development
      • 14.8.1.1. Drug Discovery & Research
      • 14.8.1.2. Biomarker Research & Application
    • 14.8.2. Diagnosis
      • 14.8.2.1. Infectious Diseases
      • 14.8.2.2. Autoimmune Diseases
      • 14.8.2.3. Cancer
      • 14.8.2.4. Cardiovascular Diseases
      • 14.8.2.5. Neuroendocrine Diseases
      • 14.8.2.6. Others
    • 14.8.3. Others
  • 14.9. Market Attractiveness, by Application
  • 14.10. Market Value Forecast, by End-user, 2017-2031
    • 14.10.1. Biotechnology & Biopharmaceutical Companies
    • 14.10.2. Academic & Research Centers
    • 14.10.3. Diagnostic Centers
    • 14.10.4. Hospitals
    • 14.10.5. Others
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Product
    • 14.13.2. By Technology
    • 14.13.3. By Type
    • 14.13.4. By Application
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Multiplex Assays Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product, 2017-2031
    • 15.2.1. Instruments
    • 15.2.2. Consumables
      • 15.2.2.1. Reagents & Kits
      • 15.2.2.2. Micropipettes & Microplates
      • 15.2.2.3. Others
    • 15.2.3. Software
  • 15.3. Market Attractiveness, by Product
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. Multiplex RT-PCR
    • 15.4.2. Flow Cytometry
    • 15.4.3. Luminescence
    • 15.4.4. Fluorescence
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Technology
  • 15.6. Market Value Forecast, By Type, 2017-2031
    • 15.6.1. Protein
      • 15.6.1.1. Planar
      • 15.6.1.2. Bead-based
    • 15.6.2. Nucleic Acid
      • 15.6.2.1. Planar
      • 15.6.2.2. Bead-based
    • 15.6.3. Cell
  • 15.7. Market Attractiveness, By Type
  • 15.8. Market Value Forecast, by Application, 2017-2031
    • 15.8.1. Research & Development
      • 15.8.1.1. Drug Discovery & Research
      • 15.8.1.2. Biomarker Research & Application
    • 15.8.2. Diagnosis
      • 15.8.2.1. Infectious Diseases
      • 15.8.2.2. Autoimmune Diseases
      • 15.8.2.3. Cancer
      • 15.8.2.4. Cardiovascular Diseases
      • 15.8.2.5. Neuroendocrine Diseases
      • 15.8.2.6. Others
    • 15.8.3. Others
  • 15.9. Market Attractiveness, by Application
  • 15.10. Market Value Forecast, by End-user, 2017-2031
    • 15.10.1. Biotechnology & Biopharmaceutical Companies
    • 15.10.2. Academic & Research Centers
    • 15.10.3. Diagnostic Centers
    • 15.10.4. Hospitals
    • 15.10.5. Others
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Product
    • 15.13.2. By Technology
    • 15.13.3. By Type
    • 15.13.4. By Application
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Multiplex Assays Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Product, 2017-2031
    • 16.2.1. Instruments
    • 16.2.2. Consumables
      • 16.2.2.1. Reagents & Kits
      • 16.2.2.2. Micropipettes & Microplates
      • 16.2.2.3. Others
    • 16.2.3. Software
  • 16.3. Market Attractiveness, by Product
  • 16.4. Market Value Forecast, by Technology, 2017-2031
    • 16.4.1. Multiplex RT-PCR
    • 16.4.2. Flow Cytometry
    • 16.4.3. Luminescence
    • 16.4.4. Fluorescence
    • 16.4.5. Others
  • 16.5. Market Attractiveness, by Technology
  • 16.6. Market Value Forecast, By Type, 2017-2031
    • 16.6.1. Protein
      • 16.6.1.1. Planar
      • 16.6.1.2. Bead-based
    • 16.6.2. Nucleic Acid
      • 16.6.2.1. Planar
      • 16.6.2.2. Bead-based
    • 16.6.3. Cell
  • 16.7. Market Attractiveness, By Type
  • 16.8. Market Value Forecast, by Application, 2017-2031
    • 16.8.1. Research & Development
      • 16.8.1.1. Drug Discovery & Research
      • 16.8.1.2. Biomarker Research & Application
    • 16.8.2. Diagnosis
      • 16.8.2.1. Infectious Diseases
      • 16.8.2.2. Autoimmune Diseases
      • 16.8.2.3. Cancer
      • 16.8.2.4. Cardiovascular Diseases
      • 16.8.2.5. Neuroendocrine Diseases
      • 16.8.2.6. Others
    • 16.8.3. Others
  • 16.9. Market Attractiveness, by Application
  • 16.10. Market Value Forecast, by End-user, 2017-2031
    • 16.10.1. Biotechnology & Biopharmaceutical Companies
    • 16.10.2. Academic & Research Centers
    • 16.10.3. Diagnostic Centers
    • 16.10.4. Hospitals
    • 16.10.5. Others
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Product
    • 16.13.2. By Technology
    • 16.13.3. By Type
    • 16.13.4. By Application
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. DiaSorin S.p.A.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Thermo Fisher Scientific, Inc.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Seegene, Inc.
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Meso Scale Diagnostics, LLC
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Abcam Limited
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. QIAGEN
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Bio-Rad Laboratories, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Merck KGaA
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Quansys Biosciences
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Illumina, Inc.
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017-2031
  • Table 05: Global Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017-2031
  • Table 11: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: North America Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017-2031
  • Table 17: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 21: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 22: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017-2031
  • Table 23: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 27: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 28: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017-2031
  • Table 29: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 33: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 34: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017-2031
  • Table 35: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 36: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Multiplex Assays Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Multiplex Assays Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Multiplex Assays Market Value Share, by Product, 2022
  • Figure 04: Global Multiplex Assays Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Multiplex Assays Market Value Share, by Technology, 2022
  • Figure 06: Global Multiplex Assays Market Revenue (US$ Mn), By Type, 2022
  • Figure 07: Global Multiplex Assays Market Value Share, By Type, 2022
  • Figure 08: Global Multiplex Assays Market Revenue (US$ Mn), by Application, 2022
  • Figure 09: Global Multiplex Assays Market Value Share, by Application, 2022
  • Figure 10: Global Multiplex Assays Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Multiplex Assays Market Value Share, by End-user, 2022
  • Figure 12: Global Multiplex Assays Market Value Share, by Region, 2022
  • Figure 13: Global Multiplex Assays Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Multiplex Assays Market Value Share Analysis, by Product, 2022-2031
  • Figure 15: Global Multiplex Assays Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 16: Global Multiplex Assays Market Value Share Analysis, by Technology, 2022-2031
  • Figure 17: Global Multiplex Assays Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 18: Global Multiplex Assays Market Value Share Analysis, By Type, 2022-2031
  • Figure 19: Global Multiplex Assays Market Attractiveness Analysis, By Type, 2023-2031
  • Figure 20: Global Multiplex Assays Market Revenue (US$ Mn), by Application, 2022
  • Figure 21: Global Multiplex Assays Market Value Share, by Application, 2022
  • Figure 22: Global Multiplex Assays Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Multiplex Assays Market Value Share, by End-user, 2022
  • Figure 24: Global Multiplex Assays Market Value Share Analysis, by Region, 2022-2031
  • Figure 25: Global Multiplex Assays Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Multiplex Assays Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Multiplex Assays Market Value Share Analysis, by Country, 2022-2031
  • Figure 29: North America Multiplex Assays Market Value Share Analysis, by Product, 2022-2031
  • Figure 30: North America Multiplex Assays Market Value Share Analysis, by Technology, 2022-2031
  • Figure 31: North America Multiplex Assays Market Value Share Analysis, By Type, 2022-2031
  • Figure 32: North America Multiplex Assays Market Value Share Analysis, by Application, 2022-2031
  • Figure 33: North America Multiplex Assays Market Value Share Analysis, by End-user, 2022-2031
  • Figure 34: North America Multiplex Assays Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 35: North America Multiplex Assays Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 36: North America Multiplex Assays Market Attractiveness Analysis, By Type, 2023-2031
  • Figure 37: North America Multiplex Assays Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 38: North America Multiplex Assays Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Europe Multiplex Assays Market Value Share Analysis, by Product, 2022-2031
  • Figure 43: Europe Multiplex Assays Market Value Share Analysis, by Technology, 2022-2031
  • Figure 44: Europe Multiplex Assays Market Value Share Analysis, By Type, 2022-2031
  • Figure 45: Europe Multiplex Assays Market Value Share Analysis, by Application, 2022-2031
  • Figure 46: Europe Multiplex Assays Market Value Share Analysis, by End-user, 2022-2031
  • Figure 47: Europe Multiplex Assays Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 48: Europe Multiplex Assays Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 49: Europe Multiplex Assays Market Attractiveness Analysis, By Type, 2023-2031
  • Figure 50: Europe Multiplex Assays Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 51: Europe Multiplex Assays Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Multiplex Assays Market Value Share Analysis, by Product, 2022-2031
  • Figure 56: Asia Pacific Multiplex Assays Market Value Share Analysis, by Technology, 2022-2031
  • Figure 57: Asia Pacific Multiplex Assays Market Value Share Analysis, By Type, 2022-2031
  • Figure 58: Asia Pacific Multiplex Assays Market Value Share Analysis, by Application, 2022-2031
  • Figure 59: Asia Pacific Multiplex Assays Market Value Share Analysis, by End-user, 2022-2031
  • Figure 60: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 61: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 62: Asia Pacific Multiplex Assays Market Attractiveness Analysis, By Type, 2023-2031
  • Figure 63: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 64: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 65: Latin America Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 68: Latin America Multiplex Assays Market Value Share Analysis, by Product, 2022-2031
  • Figure 69: Latin America Multiplex Assays Market Value Share Analysis, by Technology, 2022-2031
  • Figure 70: Latin America Multiplex Assays Market Value Share Analysis, By Type, 2022-2031
  • Figure 71: Latin America Multiplex Assays Market Value Share Analysis, by Application, 2022-2031
  • Figure 72: Latin America Multiplex Assays Market Value Share Analysis, by End-user, 2022-2031
  • Figure 73: Latin America Multiplex Assays Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 74: Latin America Multiplex Assays Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 75: Latin America Multiplex Assays Market Attractiveness Analysis, By Type, 2023-2031
  • Figure 76: Latin America Multiplex Assays Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 77: Latin America Multiplex Assays Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 78: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 81: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Product, 2022-2031
  • Figure 82: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Technology, 2022-2031
  • Figure 83: Middle East & Africa Multiplex Assays Market Value Share Analysis, By Type, 2022-2031
  • Figure 84: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Application, 2022-2031
  • Figure 85: Middle East & Africa Multiplex Assays Market Value Share Analysis, by End-user, 2022-2031
  • Figure 86: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 87: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 88: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, By Type, 2023-2031
  • Figure 89: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 90: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by End-user, 2023-2031